• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 24th September 2013

Initial Findings from Research on an EQ-5D-5L Value Set for England

Four papers presented at the EuroQol Plenary discussed preliminary findings. As reported earlier, OHE’s Prof Nancy Devlin and Prof Ben van Hout of the University of Sheffield were awarded a £457,000 grant from the Policy Research Programme (PRP) of the…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Nancy Devlin

Four papers presented at the EuroQol Plenary discussed preliminary findings.

As reported earlier, OHE’s Prof Nancy Devlin and Prof Ben van Hout of the University of Sheffield were awarded a £457,000 grant from the Policy Research Programme (PRP) of the UK’s National Institute for Health Research (NIHR) for research on an EQ-5D-5L value set for England.

 

As reported earlier, OHE’s Prof Nancy Devlin and Prof Ben van Hout of the University of Sheffield were awarded a £457,000 grant from the Policy Research Programme (PRP) of the UK’s National Institute for Health Research (NIHR) for research on an EQ-5D-5L value set for England. The EQ-5D-5L is an expanded version of the EQ-5D, able to capture subtler differences in attitudes about health states. Widely used in the UK and internationally to measure patients’ self-reported health, these instruments are accompanied by “value sets”—numerical summaries of the preferences of the general public about living in certain states of health, along a continuum from “good” to “bad”. One of the applications of these value sets is to produce estimates for quality-adjusted life years (QALYs), which in turn help inform resource allocation decisions.

Although some research and analysis still is in progress, initial findings from the project were described in four papers presented at the 30th EuroQol Plenary Meeting in September[1]. Since results still are preliminary, the papers are not yet available publicly. Further modelling work on the data is underway, with the final value set and related methodological papers to be released by the end of 2013.

The project included careful monitoring of the integrity of the data during and after data collection. The results are important not only as a basis for modelling in this study, but also as guidance on good practice for other studies intended to create EQ-5D-5L data sets. The findings include, for example, that respondents appeared to find the five-level instrument more challenging to use than the three-level—for instance, in differentiating between “serious” and “extreme” problems with health.

Quite apart from technical challenges in eliciting health-state preferences are issues about how to use individuals’ data to represent society’s preferences. A further paper presented at the EuroQol meeting by OHE’s Nancy Devlin and Ken Buckingham (University of Otago) discussed the normative issues in selecting what measure of “average” preferences should be used[2]. The average preference of society (the mean), for example, is not the necessarily the same as the preference of the average person (the median). Which option is chosen has an important impact on the final value set. Finding little guidance on this issue from a review of the literature, this paper develops a set of criteria applicable in evaluating alternative approaches.

In addition to Nancy Devlin and Ben van Hout, the project team for this research includes Koonal Shah and Yan Feng from OHE and Brendan Mulhern from the University of Sheffield. Each co-authored papers presented at the EuroQol Scientific Plenary. As reported in our earlier post, the project has been guided by an advisory group comprising senior staff from the English Department of Health, NICE and external academics. 

This is an independent report commissioned and funded by the Policy Research Programme in the Department of Health. The views expressed are not necessarily those of the Department.

For further information, please contact Prof Nancy Devlin at OHE.

Earlier OHE research

This project builds on previous research under an NIHR PRP grant for methodological research that was completed by Prof Nancy Devlin and colleagues at OHE, in collaboration with others: An interim EQ-5D-5L value set for England and development of EQ-5D-5L valuation methods. That research contributed to the development and testing of preference elicitation methods as reported in: Devlin, N., Buckingham, K., Tsuchiya, A., Shah, K., Tilling, C., Wilkinson, G. and van Hout B. (2013) A comparison of alternative variants of the lead and lag time TTO. Health Economics. 22(5), 517-532.

The project also produced data that helped create an interim value set for the EQ-5D-5L based on mapping to EQ-5D value sets. This is reported in: van Hout, B., Janssen, M.F., Feng, Y-S., Kohlman, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P. and Pickard, S. (2012) Interim scoring for EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health. 15(5), 708-715.

Papers reporting on a multi-country pilot study to test the methods used in EQ-5D-5L value set studies was published recently in a special issue of the European Journal of Health Economics,co-edited by Nancy Devlin and Paul Krabbe.

 


[1] The results to date are based only on interviews conducted in England. Data collection of samples of the general public in Scotland, Northern Ireland and Wales are in progress. These will be combined with the English data to model a UK value set to complement the value set for England.
 
[2]Devlin, N. and Buckingham, K. (2013) What is the normative bias for selecting the measure of average’ preferences to use in social choices? Paper presented at the 30th EuroQol Plenary Meeting. Montreal. 12-13 September.
 
Nancy Devlin
Prof Nancy Devlin

 

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • External Publications

Related News

  • News
  • September 2020

Establishing a Reasonable Price for an Orphan Drug

Read more
  • News
  • April 2020

Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support

Read more
  • News
  • April 2020

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

Read more
  • News
  • March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!